Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2002 | View Paper
“Finally, a short-term treatment with a high dose of methylcobalamin , which reduces Hcy levels, was effective in improving compound motor action potentials in patients with ALS.”
European review for medical and pharmacological sciences • 2016 | View Paper
“ MeCbl decreases Hcy induced motor neuron death in vitro in a hybrid cell line derived from motor neuron-neuroblastoma and may play a role in the treatment of late stage ALS where HCy levels are increased in animal models of ALS.”
“ MeCbl inhibited caspase 3/7 activation by homocysteine in a time- and dose-dependent manner, whereas MTHF had no effect.”
Toxicology and applied pharmacology • 2011 | View Paper
“The second-order rate constant for demethylation of methylcobalamin by Hcy is elevated 60-fold and that for methylation of cob(I)alamin is elevated 120-fold.”